User Fees and Refunds for Premarket Notification Submissions (510(k)s): Guidance for Industry and Food and Drug Administration Staff

Information

Type

Guidance

Regulated products

Biologics, Medical Devices

Topics

Premarket

Published

October 5, 2022

Last updated

October 6, 2022

Description

This document provides guidance on user fees and refunds for premarket notification submissions (510(k)s) to the FDA.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed